Showing results (1-10 of 237) with videos related to
Sort By:
Pageof 24
Biomedical and Environmental Sciences : BES|October 7, 1997
Ebselen--an in vivo immune response modifierA Wendel, S Kuesters, G TiegsBiochemical Pharmacology|July 1, 1986
A novel biologically active seleno-organic compound--VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in miceA Wendel, G TiegsBiochemical Pharmacology|August 15, 1987
Evidence for the involvement of a reperfusion injury in galactosamine/endotoxin-induced hepatitis in miceA Wendel, G Tiegs, C WernerThe Journal of Clinical Investigation|July 1, 1992
A T cell-dependent experimental liver injury in mice inducible by concanavalin AG Tiegs, J Hentschel, A WendelBiochemical Pharmacology|August 1, 1985
A novel biologically active seleno-organic compound--V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenaseH Safayhi, G Tiegs, A WendelBiochemical Pharmacology|September 15, 1990
Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF alpha in galactosamine-sensitized miceG Tiegs, M Niehörster, A WendelBiochemical Pharmacology|February 15, 1989
Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in miceG Tiegs, M Wolter, A WendelEicosanoids|January 1, 1992
The role of leukotriene D4 in septic shock modelsT Hartung, G Tiegs, A WendelProgress in Clinical and Biological Research|January 1, 1987
Protection by ebselen against endotoxin shock in rats or mice sensitized by galactosamineK H Konz, G Tiegs, A WendelPageof 24